DV
Dividend Vision

ASBP — Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. (ASBP)

Total return is -99.9% over the past 4.3 years, 186.9 points behind SPY at 87.0%. Its deepest 1-year drawdown was 99.3%.

Aspire Biopharma Holdings is an equity fund focused on the healthcare sector, specifically within the biopharma industry. With limited publicly available data on its distribution frequency, yield profile, and expense ratio, the fund's complete income and cost characteristics are not fully transparent. This fund may appeal to investors seeking exposure to biopharma equities, though prospective investors should review the fund's prospectus for detailed information on its strategy, fees, and distribution policies.

ASBP key facts

Asset type
Stock
Asset class
Equity
Inception date
04/11/2022
Distribution frequency
None
Last close
$7.85
Market cap
$10,167,587
Average volume
34757.0
Beta
0.111
Payout ratio
0.0
Forward P/E
0.0
EPS
$-7.09